Cardiovascular Drugs: Classification based on Therapeutic Indications
Classification of Systems-I
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 6, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Tapan Kumar Behera1, Siddhartha Sathia2, Sibarama Panigrahi3
1Centre of Excellence in Natural Products and Therapeutics, Department of Biotechnology and Bioinformatics, Sambalpur University, Jyoti Vihar, Burla, Sambalpur, Odisha, India.
Machine learning (ML) models offer a cost-effective digital diagnosis for cardiovascular diseases (CVDs). The Extra Tree Classifier excels in accuracy and precision, while XGBoost leads in recall, kappa, and F1 scores for CVD classification.
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: